OBI Pharma Balance Sheet Health
Financial Health criteria checks 5/6
OBI Pharma has a total shareholder equity of NT$4.0B and total debt of NT$54.7M, which brings its debt-to-equity ratio to 1.4%. Its total assets and total liabilities are NT$4.5B and NT$569.2M respectively.
Key information
1.4%
Debt to equity ratio
NT$54.74m
Debt
| Interest coverage ratio | n/a |
| Cash | NT$1.84b |
| Equity | NT$3.96b |
| Total liabilities | NT$569.21m |
| Total assets | NT$4.53b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 4174's short term assets (NT$2.1B) exceed its short term liabilities (NT$135.0M).
Long Term Liabilities: 4174's short term assets (NT$2.1B) exceed its long term liabilities (NT$434.2M).
Debt to Equity History and Analysis
Debt Level: 4174 has more cash than its total debt.
Reducing Debt: 4174's debt to equity ratio has increased from 1% to 1.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4174 has sufficient cash runway for 11 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: 4174 is forecast to have sufficient cash runway for 8 months based on free cash flow estimates, but has since raised additional capital.